Skip to main content
. 2015 Aug 18;10:5205–5218. doi: 10.2147/IJN.S84326

Figure 9.

Figure 9

Anticancer abilities of different formulations containing SH-ASA and/or Cur against SKOV3 and ES-2 cells after treatment for 48 hours.

Notes: (A) SKOV3 cells; (B) ES-2 cells.

Abbreviations: SH-ASA, SH-aspirin; NPs, nanoparticles; Cur, curcumin.